How Israel is fighting the global antibiotic overuse

The United States is among the most efficient at taking the antibiotic penicillin out of its supply chain.

But as the global population grows and antibiotic use in hospitals and nursing homes increases, many nations are now relying on antibiotics to fight infections and prevent deaths.

As the world’s largest producer of antibiotics, Israel is among those who have the biggest share of antibiotics produced and distributed in the world.

Since 2008, Israel has produced almost 70 percent of the world supply, according to figures from the International Organization for Standardization.

The rest is made by countries in Asia, Africa, the Middle East, South America and Europe.

But even as the country produces a large amount of antibiotics for export, it still accounts for less than 2 percent of global production.

Israel has been grappling with the rise of antibiotic-resistant bacteria for years.

The world has had a major decline in antibiotic resistance, and the world is in the middle of a major pandemic that is killing millions of people.

But Israel’s share of the global production of antibiotics remains below the global average, according with data compiled by the IOM.

As a result, Israel’s exports of antibiotics have dropped dramatically, to about 1,100 metric tons in 2016 from more than 2,700 tons a decade ago.

The country’s imports of antibiotics fell to about 5,000 metric tons last year from more about 11,000 tons in 2015, according data compiled for the World Health Organization by Israel’s Ministry of Health.

Israel has been trying to lower its imports by about 100 metric tons a year, but that has been harder to achieve in recent years, said David Ben-Ari, a professor of pharmaceuticals at Bar-Ilan University.

In recent years the country has been experimenting with new manufacturing methods, including using a process known as biosafety in-situ, or BIS, in which bacteria are grown inside a sealed chamber.

The bacteria then grow in the surrounding environment and are then sprayed onto a surface.

The process can be done cheaply and the results have been good, but the use of the process has also resulted in some bacteria resistance, said Dr. Dan Dib, a researcher with the Israeli Center for Applied Biological Technologies.

Israel is one of the top producers of BIS in the Middle-East and Europe, with its exports of the drug topping 10,000 tonnes in 2016, according the World Trade Organization.

Israel exported about 1.4 million metric tons of the antibiotic to Europe in 2017.

Dr. Dib said Israel needs to develop more effective ways to manufacture and distribute the drug, but there is little hope of being able to control antibiotic production.

While Israel has a high number of antibiotics that are produced by a single country, the U.S. is also an active producer of antibiotic drugs and has the third largest antibiotic market in the World, according a World Health Assembly report released last year.

In 2017, the United States was the world leader in antibiotics production with 2.4 billion metric tons, the report found.

That is up from just over 800 million metric tonnes in 2010, according it.

The report noted that while the U,S.

has made progress in controlling antibiotic production, the country’s total antibiotics production is not on track to keep up with the world as a whole.

The U.K., Canada and Japan are the biggest producers of antibiotics in the global supply chain, the World Resources Institute, an international trade group, said in a report last year, citing a report by the International Council for Agricultural Research.

The U.N. and other international organizations have warned that the global drug trade is becoming more and more dependent on antibiotics.

The drugs can be used to treat illnesses from tuberculosis to malaria and they can be manufactured in countries where there are no antibiotics available, such as the Middle Eastern countries, South Asia and Africa.

But the report also noted that the world economy is growing faster than most other areas, and as more people become wealthier and the number of infections in developing countries increases, the supply of antibiotics will need to keep rising.

The United States, which produces about 10 percent of world antibiotics, has also been experimenting to reduce the use and spread of antibiotics.

A U. S. Department of Agriculture report published last year said that the U.,S.

must limit the use or abuse of antibiotics if the global pandemic is to be contained.